HYZAAR Side Effects

6790976-X | Aspartate Aminotransferase Abnormal, Blood Calcium Increased, Thyroid Neoplasm
on Jun 18, 2010 Female patient from UNITED STATES , 60 years of age, weighting 172.0 lb, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase abnormal, blood calcium increased, thyroid neoplasm. Hyzaar dosage: .

6782136-3 | Hypokalaemia, Hyponatraemia
Patient was taking Hyzaar (View Usage). Patient had the following side effects: hypokalaemia, hyponatraemia on Jun 15, 2010 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with hypertension, hiatus hernia, major depression, osteoporosis (What is osteoporosis?) and. Hyzaar dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), LASIX (View Lasix Review and Lasix Label ), STABLON (View Stablon Review and Stablon Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), BONIVA (View Boniva Review and Boniva Label ), NORMACOL (STERCULIA) (View Normacol (sterculia) Review and Normacol (sterculia) Label ), CARBOSYMAG (View Carbosymag Review and Carbosymag Label ), SPASFON (View Spasfon Review and Spasfon Label ). Patient was hospitalized.

6781509-2 | Alopecia
Adverse event was reported on Jun 17, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: 1 Daily) was diagnosed with hypertension and. Location: UNITED STATES , weighting 150.0 lb, After Hyzaar was administered, patient had the following side effects: alopecia. During the same period patient was treated with AMLODIPINE (1 Daily) (View Amlodipine Review and Amlodipine Label ).

6779912-X | Shock
on Jun 08, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: shock. Hyzaar dosage: . During the same period patient was treated with ATELEC (View Atelec Review and Atelec Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).


6775432-7 | Acute Myocardial Infarction
on Jun 07, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: acute myocardial infarction. Hyzaar dosage: . During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), BUSPIRONE HYDROCHLORIDE (View Buspirone Hydrochloride Review and Buspirone Hydrochloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PLAVIX (View Plavix Review and Plavix Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6770752-4 | Blood Glucose Increased, Glucose Urine Present, Glycosylated Haemoglobin Increased, Thirst
Patient was taking Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: blood glucose increased, glucose urine present, glycosylated haemoglobin increased, thirst on Jun 08, 2010 from JAPAN Additional patient health information: Male patient , 44 years of age, weighting 240.3 lb, was diagnosed with hypertension, hyperuricaemia and. Hyzaar dosage: . During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ), ZYLORIC (View Zyloric Review and Zyloric Label ). Patient was hospitalized.

6769477-0 | Osteoarthritis
Adverse event was reported on May 28, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: 1 Tab/daily/po) was diagnosed with hypertension and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: osteoarthritis (What is osteoarthritis?). During the same period patient was treated with BASED OD (View Based Od Review and Based Od Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), EBASTINE (View Ebastine Review and Ebastine Label ), GASTER (View Gaster Review and Gaster Label ), ITOROL (View Itorol Review and Itorol Label ), JUVELA N (View Juvela N Review and Juvela N Label ), LANDEL (View Landel Review and Landel Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6769184-4 | Blood Uric Acid Increased
on May 24, 2010 Female patient from JAPAN , 51 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: blood uric acid increased. Hyzaar dosage: 1 Tab Daily, Po.

6768204-0 | Adverse Event, Constipation, Dry Mouth, Scoliosis
on Jun 09, 2010 Female patient from UNITED STATES , 74 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: adverse event, constipation (What is constipation?), dry mouth, scoliosis. Hyzaar dosage: . During the same period patient was treated with TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), XALATAN (View Xalatan Review and Xalatan Label ), TIMOLOL (View Timolol Review and Timolol Label ). Patient was hospitalized.

6768203-9 | Cardiac Fibrillation, Malaise, Oedema Mouth, Pruritus, Swollen Tongue
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac fibrillation, malaise, oedema mouth, pruritus, swollen tongue on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 88 years of age, was diagnosed with hypertension and. Hyzaar dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LUMIGAN (View Lumigan Review and Lumigan Label ). Patient was hospitalized.

6768197-6 | Dry Mouth, Dry Throat, Logorrhoea, Salivary Gland Disorder, Swelling Face
Adverse event was reported on Jun 03, 2010 by a Male patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension, fluid retention and. Location: UNITED STATES , 74 years of age, Patient had the following side effects: dry mouth, dry throat, logorrhoea, salivary gland disorder (What is salivary gland disorder?), swelling face. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), CRESTOR (View Crestor Review and Crestor Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

6767032-X | Amniotic Fluid Volume Decreased
on May 31, 2010 Female patient from JAPAN , 36 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: amniotic fluid volume decreased. Hyzaar dosage: .

6766541-7 | Blood Calcium Increased, Thyroid Neoplasm
on Jun 02, 2010 Female patient from UNITED STATES , 60 years of age, was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: blood calcium increased, thyroid neoplasm. Hyzaar dosage: .

6766540-5 | Renal Failure Acute, Rhabdomyolysis
Patient was taking Hyzaar (View Usage). Patient had the following side effects: renal failure acute, rhabdomyolysis on Jun 03, 2010 from JAPAN Additional patient health information: Female patient , 88 years of age, weighting 74.96 lb, was diagnosed with hypertension, angina pectoris, cardiac failure, constipation (What is constipation?), hyperlipidaemia, gastric ulcer and. Hyzaar dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DIART (View Diart Review and Diart Label ), FRANDOL TAPE S (View Frandol Tape S Review and Frandol Tape S Label ), MAGMITT (View Magmitt Review and Magmitt Label ), ADALAT (View Adalat Review and Adalat Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), SIGMART (View Sigmart Review and Sigmart Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6762630-1 | Blood Glucose Increased, Glucose Urine Present, Glycosylated Haemoglobin Increased, Thirst
Adverse event was reported on Jun 01, 2010 by a Male patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension, hyperuricaemia and. Location: JAPAN , 44 years of age, weighting 240.3 lb, After Hyzaar was administered, patient had the following side effects: blood glucose increased, glucose urine present, glycosylated haemoglobin increased, thirst. During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), CALBLOCK (View Calblock Review and Calblock Label ). Patient was hospitalized.

6762612-X | Asthenia, Blood Creatine Phosphokinase Increased, Hypokalaemia, Metabolic Alkalosis
on May 31, 2010 Female patient from JAPAN , 82 years of age, weighting 92.59 lb, was diagnosed with hypertension, back pain (What is back pain?) and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood creatine phosphokinase increased, hypokalaemia, metabolic alkalosis. Hyzaar dosage: . During the same period patient was treated with SHAKUYAKU KANZO TO (Divided Dose Frequency U) (View Shakuyaku-kanzo-to Review and Shakuyaku-kanzo-to Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6754258-4 | Altered State Of Consciousness, Hypokalaemia, Hyponatraemia
on May 27, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with hypertension, back pain (What is back pain?), lipids abnormal, angina pectoris and was treated with Hyzaar (View Usage). Patient had the following side effects: altered state of consciousness, hypokalaemia, hyponatraemia. Hyzaar dosage: . During the same period patient was treated with SYAKUYAKU KANZOTO (View Syakuyaku-kanzoto Review and Syakuyaku-kanzoto Label ), TOWARAT (View Towarat Review and Towarat Label ), LIVALO (View Livalo Review and Livalo Label ), BUFFERIN (View Bufferin Review and Bufferin Label ). Patient was hospitalized.

6752024-7 | Cardiovascular Disorder, Tremor
Patient was taking Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: cardiovascular disorder, tremor on May 18, 2010 from CANADA Additional patient health information: Female patient , 84 years of age, was diagnosed with hypertension and. Hyzaar dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

6752017-X | Ageusia, Anosmia
Adverse event was reported on May 18, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: CANADA , 82 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: ageusia, anosmia. During the same period patient was treated with ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), UBIDECARENONE (View Ubidecarenone Review and Ubidecarenone Label ).

6752012-0 | Blood Pressure Increased, Jaundice, Oxygen Saturation Decreased
on May 18, 2010 Female patient from CANADA , 68 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: blood pressure increased, jaundice (What is jaundice?), oxygen saturation decreased. Hyzaar dosage: . During the same period patient was treated with AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), WARFARIN (View Warfarin Review and Warfarin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6752006-5 | Inappropriate Antidiuretic Hormone Secretion
on May 25, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: inappropriate antidiuretic hormone secretion. Hyzaar dosage: . During the same period patient was treated with ENALAMERCK (View Enalamerck Review and Enalamerck Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), MICARDIS (View Micardis Review and Micardis Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), VASOTEC (View Vasotec Review and Vasotec Label ). Patient was hospitalized.

6750599-5 | Cough, Product Substitution Issue
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: cough, product substitution issue on May 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 205.0 lb, was diagnosed with congestive cardiomyopathy and. Hyzaar dosage: 50-12.5mg 1/day Oral.

6744301-0 | Dehydration, Feeling Hot, Syncope
Adverse event was reported on May 17, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , 62 years of age, weighting 127.9 lb, Patient had the following side effects: dehydration, feeling hot, syncope. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), BUSPAR (View Buspar Review and Buspar Label ). Patient was hospitalized.

6744292-2 | Rhabdomyolysis
on May 18, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: rhabdomyolysis. Hyzaar dosage: . During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

6738307-5 | Acute Coronary Syndrome, Pneumonia, Pulmonary Oedema, Toxic Shock Syndrome
on May 18, 2010 Female patient from CANADA , 73 years of age, weighting 176.4 lb, was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, pneumonia (What is pneumonia?), pulmonary oedema, toxic shock syndrome. Hyzaar dosage: . During the same period patient was treated with FOSAMAX PLUS D (View Fosamax Plus D Review and Fosamax Plus D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6738305-1 | Diarrhoea, Hypotension, Nausea, Pigmentation Disorder, Respiratory Distress
Patient was taking Hyzaar (View Usage). Patient had the following side effects: diarrhoea, hypotension, nausea (What is nausea?), pigmentation disorder, respiratory distress on May 18, 2010 from CANADA Additional patient health information: Female patient , 73 years of age, weighting 194.0 lb, . Hyzaar dosage: . During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6738146-5 | Stress Cardiomyopathy
Adverse event was reported on May 10, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: 1 Dose/daily Po) was diagnosed with hypertension, gastritis and. Location: JAPAN , 73 years of age, After Hyzaar was administered, patient had the following side effects: stress cardiomyopathy. During the same period patient was treated with LANSOPRAZOLE (15 Mg/bid Po) (View Lansoprazole Review and Lansoprazole Label ), TAB GANATON (ITOPRIDE HYDROCHLORIDE) (50 Mg/tid Po) (View Tab Ganaton (itopride Hydrochloride) Review and Tab Ganaton (itopride Hydrochloride) Label ), AMLODIPINE BESYLATE (2.5 Mg/daily Po) (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6736529-0 | Hypokalaemia, Primary Hyperaldosteronism
on May 12, 2010 Male patient from JAPAN , 82 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, primary hyperaldosteronism. Hyzaar dosage: 1 Tab/daily Po. During the same period patient was treated with CONIEL (View Coniel Review and Coniel Label ), GLIMICRON (View Glimicron Review and Glimicron Label ), PEPCID RPD (View Pepcid Rpd Review and Pepcid Rpd Label ).

6736413-2 | Inappropriate Antidiuretic Hormone Secretion
on May 14, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion. Hyzaar dosage: . During the same period patient was treated with ENALAMERCK (View Enalamerck Review and Enalamerck Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), VASOTEC (View Vasotec Review and Vasotec Label ). Patient was hospitalized.

6736392-8 | Blood Calcium Increased, Thyroid Neoplasm
Patient was taking Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: blood calcium increased, thyroid neoplasm on May 17, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Hyzaar dosage: .

6732991-8 | Dehydration, Feeling Hot, Syncope
Adverse event was reported on May 17, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , 62 years of age, weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: dehydration, feeling hot, syncope. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), BUSPAR (View Buspar Review and Buspar Label ). Patient was hospitalized.

6720256-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Urea Increased, Hyperthermia, Refusal Of Treatment By Patient
on Apr 27, 2010 Male patient from JAPAN , 31 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, hyperthermia, refusal of treatment by patient. Hyzaar dosage: 1 Tab/daily Po. During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6717846-7 | Blood Potassium Decreased, Bursitis, Fall, Gait Disturbance, Migraine, Muscle Spasms, Pain In Extremity
on Apr 30, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: blood potassium decreased, bursitis (What is bursitis?), fall (What is fall?), gait disturbance, migraine (What is migraine?), muscle spasms, pain in extremity. Hyzaar dosage: .

6711903-7 | Pneumonia
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?) on Apr 26, 2010 from JAPAN Additional patient health information: Male patient , 84 years of age, . Hyzaar dosage: . During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), NORVASC (View Norvasc Review and Norvasc Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), OMEPRAL (View Omepral Review and Omepral Label ), PURSENNID (View Pursennid Review and Pursennid Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ARGAMATE JELLY (View Argamate Jelly Review and Argamate Jelly Label ). Patient was hospitalized.

6708693-0 | Dry Mouth, Feeling Abnormal, Intracranial Aneurysm, Lethargy, Reproductive Tract Disorder
Adverse event was reported on Apr 28, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with blood pressure (What is blood pressure?) and. Location: UNITED STATES , 53 years of age, Patient had the following side effects: dry mouth, feeling abnormal, intracranial aneurysm, lethargy, reproductive tract disorder. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ). Patient was hospitalized.

6704363-3 | Lupus-like Syndrome
on Apr 22, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: lupus-like syndrome. Hyzaar dosage: . During the same period patient was treated with ATELEC (View Atelec Review and Atelec Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ).

6704342-6 | Abdominal Distension, Adverse Event, Oedema Peripheral
on Apr 26, 2010 Female patient from UNITED STATES , 82 years of age, was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, adverse event, oedema peripheral. Hyzaar dosage: .

6700729-6 | Dehydration, Feeling Hot, Syncope
Patient was taking Hyzaar (View Usage). Patient had the following side effects: dehydration, feeling hot, syncope on Apr 22, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with blood pressure (What is blood pressure?) and. Hyzaar dosage: . During the same period patient was treated with BUSPAR (View Buspar Review and Buspar Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6700714-4 | Glomerulonephritis Rapidly Progressive
Adverse event was reported on Apr 15, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 60 years of age, After Hyzaar was administered, patient had the following side effects: glomerulonephritis rapidly progressive. Patient was hospitalized.

6698894-2 | Gait Disturbance, Hypochloraemia, Hyponatraemia
on Apr 16, 2010 Female patient from JAPAN , 82 years of age, weighting 116.8 lb, was diagnosed with hypertension, hepatic function abnormal, hepatitis c (What is hepatitis c?), depression (What is depression?) and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance, hypochloraemia, hyponatraemia. Hyzaar dosage: . During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), ELAVIL (View Elavil Review and Elavil Label ). Patient was hospitalized.

6698879-6 | Acute Prerenal Failure, Bronchitis
on Apr 14, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with hypertension, oedema peripheral, blood cholesterol increased, rhinitis allergic, oesophagitis, bronchitis (What is bronchitis?) and was treated with Hyzaar (View Usage). Patient had the following side effects: acute prerenal failure, bronchitis (What is bronchitis?). Hyzaar dosage: . During the same period patient was treated with DIART (View Diart Review and Diart Label ), CRESTOR (View Crestor Review and Crestor Label ), CLARITIN REDITABS (View Claritin Reditabs Review and Claritin Reditabs Label ), OMEPRAL (View Omepral Review and Omepral Label ), KLARICID (View Klaricid Review and Klaricid Label ), PL GRANULES (View Pl-granules Review and Pl-granules Label ), ASVERIN (View Asverin Review and Asverin Label ), SOLON (View Solon Review and Solon Label ). Patient was hospitalized.

6697679-0 | Dry Skin, Eczema, Pain, Scleroderma, Skin Exfoliation, Skin Ulcer
Patient was taking Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: dry skin, eczema (What is eczema?), pain (What is pain?), scleroderma (What is scleroderma?), skin exfoliation, skin ulcer on Apr 22, 2010 from FRANCE Additional patient health information: Female patient , 72 years of age, was diagnosed with metastases to peritoneum, nausea (What is nausea?) and. Hyzaar dosage: . During the same period patient was treated with HYCAMTIN (View Hycamtin Review and Hycamtin Label ), ZOPHREN (View Zophren Review and Zophren Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ).

6692639-8 | Fall, Joint Sprain
Adverse event was reported on Apr 20, 2010 by a Female patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension, pain in extremity and. Location: FRANCE , 87 years of age, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), joint sprain. During the same period patient was treated with CELIPROLOL HYDROCHLORIDE (View Celiprolol Hydrochloride Review and Celiprolol Hydrochloride Label ), LOPRAZOLAM MESYLATE (View Loprazolam Mesylate Review and Loprazolam Mesylate Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), GINKGO (View Ginkgo Review and Ginkgo Label ), IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ). Patient was hospitalized.

6686748-7 | Dehydration, Feeling Hot, Syncope
on Apr 13, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with blood pressure (What is blood pressure?) and was treated with Hyzaar (View Usage). Patient had the following side effects: dehydration, feeling hot, syncope. Hyzaar dosage: . During the same period patient was treated with BUSPAR (View Buspar Review and Buspar Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6686658-5 | Convulsion
on Apr 16, 2010 Male patient from CANADA , weighting 171.5 lb, was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: convulsion. Hyzaar dosage: 100/25 Mg X 1 Once Po.

6684872-6 | Asthenia, Blood Creatine Phosphokinase Increased, Hypokalaemia, Metabolic Alkalosis, Pseudoaldosteronism
Patient was taking Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood creatine phosphokinase increased, hypokalaemia, metabolic alkalosis, pseudoaldosteronism on Apr 08, 2010 from JAPAN Additional patient health information: Female patient , 82 years of age, weighting 92.59 lb, was diagnosed with hypertension, back pain (What is back pain?) and. Hyzaar dosage: . During the same period patient was treated with SHAKUYAKU KANZO TO (View Shakuyaku-kanzo-to Review and Shakuyaku-kanzo-to Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6684868-4 | Tendon Rupture
Adverse event was reported on Apr 09, 2010 by a Male patient taking Hyzaar (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: SPAIN , 56 years of age, Patient had the following side effects: tendon rupture.

6683123-6 | Anxiety, Blood Pressure Increased, Dyspnoea, Feeling Abnormal, Feeling Drunk, Stress, Tinnitus
on Apr 07, 2010 Female patient from UNITED STATES , 75 years of age, was diagnosed with hypertension and was treated with Hyzaar (View Usage). After Hyzaar was administered, patient had the following side effects: anxiety (What is anxiety?), blood pressure increased, dyspnoea, feeling abnormal, feeling drunk, stress (What is stress?), tinnitus (What is tinnitus?). Hyzaar dosage: . During the same period patient was treated with OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ).

6677177-0 | Acute Prerenal Failure
on Apr 01, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with hypertension, oedema peripheral, blood cholesterol increased, rhinitis allergic, oesophagitis, bronchitis (What is bronchitis?) and was treated with Hyzaar (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure. Hyzaar dosage: . During the same period patient was treated with DIART (View Diart Review and Diart Label ), CRESTOR (View Crestor Review and Crestor Label ), CLARITIN REDITABS (View Claritin Reditabs Review and Claritin Reditabs Label ), OMEPRAL (View Omepral Review and Omepral Label ), KLARICID (View Klaricid Review and Klaricid Label ), PL GRANULES (View Pl-granules Review and Pl-granules Label ), ASVERIN (View Asverin Review and Asverin Label ), SOLON (View Solon Review and Solon Label ). Patient was hospitalized.

6673202-1 | Anxiety, Blood Pressure Increased, Dyspnoea, Feeling Abnormal, Feeling Drunk, Stress, Tinnitus
Patient was taking Hyzaar (View Usage). Patient had the following side effects: anxiety (What is anxiety?), blood pressure increased, dyspnoea, feeling abnormal, feeling drunk, stress (What is stress?), tinnitus (What is tinnitus?) on Apr 01, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with hypertension and. Hyzaar dosage: . During the same period patient was treated with OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ).